See what questions
a doctor would ask.
A pharmaceuticals company has launched a once daily medication called Foltral (alfuzosin) to treat benign prostatic hyperplasia (BPH) to a urological disorder. The medication is well tolerated and has a lower incidence of postural hypotension, syncope, erectile dysfunction and ejaculatory disorders compared to the alternative alpha-blockers. BPH is very common and affects more than half of men over 60 and about 80% of those over 80. Untreated BPH can lead to urinary tract infections, bladder and kidney damage, bladder stones and incontinence.
Source: summary of medical news story as reported by The Financial Express
About: New BPH drug has fewer side effects
Date: 22 November 2004
Source: The Financial Express
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City